Ultragenyx Pharmaceutical Inc RARE Valuation Ratios and Share Stats

S&P TSX Capped Composite...

US Dollar vs CAD

Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

Get Started

Home
Investing
Stocks
USA
NASDAQ
Ultragenyx Pharmaceutical Inc (RARE)
Ultragenyx Pharmaceutical Inc (RARE) Financials

Statistics

Annual Quarterly

Year End December 30 2023	2016	2017	2018	2019	2020	2021	2022	2023
	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)
Return on Assets (%)	-44.696	-58.589	-32.655	-43.419	-12.889	-27.668	-46.118	-39.957
Return on Equity (%)	-48.927	-70.476	-39.826	-63.79	-20.636	-43.721	-110.963	-193.225
Return on Invested Capital (%)	-63.503	-77.704	-73.718	-69.585	-34.388	-33.593	-64.74	-57.653
Operating Margin (%)	-184841.353	-12187.519	-382.75	-384.046	-56.107	-120.533	-181.298	-124.919
Net Profit Margin (%)	-184867.669	-11567.343	-383.748	-388.305	-68.836	-129.202	-194.705	-139.698
Book Value Per Share	11.493	4.472	8.558	8.305	14.649	10.778	2.108	0.788
Earnings Per Share	-5.962	-6.841	-3.885	-6.963	-2.792	-6.547	-10.078	-7.388
Cash Per Share	3.907	2.275	2.23	7.497	10.678	4.436	1.894	2.601
Working Capital Per Share	8.279	4.496	8.801	12.928	16.548	9.737	8.871	5.501
Operating Profit Per Share	0.003	0.059	0.99	1.637	3.964	4.837	4.818	4.784
EBIT Per Share	-5.961	-7.208	-3.875	-6.906	-2.774	-6.532	-9.997	-7.41
EBITDA Per Share	-5.961	-7.208	-3.875	-6.906	-2.774	-6.532	-9.997	-7.41
Free Cash Flow Per Share	-5.798	-6.909	-4.189	-6.681	-2.319	-5.684	-8.256	-7.135

Liquidity Ratios

Year End December 30 2023	2016	2017	2018	2019	2020	2021	2022	2023
Current Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Quick Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Inventory Turnover (Days)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Shares Outstanding	41.24M	44.17M	50.86M	57.84M	66.82M	69.35M	70.2M	N/A

Key Stats and Ratios

Year End December 30 2023	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024
	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)
Shares Outstanding	70.2M	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Assets (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Equity (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Invested Capital (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Margin (%)	N/A	-147.111	N/A	N/A	N/A	-141.852	N/A	N/A
Net Profit Margin (%)	N/A	-163.163	N/A	N/A	N/A	-156.831	N/A	N/A
Sales Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Book Value Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Earnings Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Cash Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Working Capital Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Profit Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
EBIT Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
EBITDA Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Free Cash Flow Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Current Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Quick Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Inventory Turnover (Days)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Key Stats and Ratios

Market Cap	4.35B
Price to Earnings Ratio	-7.21
Price to Sales Ratio	10.08
Price to Cash Ratio	20.49
Price to Book Ratio	15.89
Dividend Yield	-

Share Statistics

Shares Outstanding	92.34M
Average Volume (1 week)	689.6k
Average Volume (1 Month)	963.43k
52 Week Change	21.44%
52 Week High	60.37
52 Week Low	37.02

More Ratios Coming Soon!

Ultragenyx Pharmaceutical

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions